Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subconjunctival Bevacizumab in Diabetic Macular Edema
NCT02796183Completed
- Sponsor
- Neon Hospital
- Start
- Jan 2015
- Primary completion
- Apr 2016
- Modality
- Monoclonal Antibodies
01
Overview
Open-label, single-arm trial of RPH-001 in diabetic macular edema (DME), sponsored by Neon Hospital. Primary endpoint: Central Macular Thickness at 1 year. Started Jan 2015; status: completed.
02
Drugs
RPH-001
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02796183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02796183.